Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

July 8, 2014

Primary Completion Date

July 29, 2020

Study Completion Date

December 31, 2033

Conditions
Small Cell Lung Carcinoma
Interventions
RADIATION

45 Gy in 30 fractions

3D conformal thoracic radiotherapy at a total dose of 45 Gy in 30 fractions, 2 fractions per day, 5 days a week

RADIATION

60 Gy in 40 fractions

3D conformal thoracic radiotherapy at a total dose of 60 Gy in 40 fractions, 2 fractions per day, 5 days a week. If doses to organs at risk exceed normal tissue tolerance, the dose may be lowered to a minimum of 54 Gy.

Trial Locations (22)

Unknown

Rigshospitalet København, Copenhagen

Odense University Hospital, Odense

Ålesund sykehus, Ålesund

Haukeland Universitetssykehus, Bergen

Vestre Viken HF, Drammen Sykehus, Drammen

Førde Sentralsykehus, Førde

Sykehuset Innlandet Gjøvik, Gjøvik

Haugesund sykehus, Haugesund

Sykehuset Levanger, Levanger

Sykehuset Namsos, Namsos

Akershus Universitetssykehus, Oslo

Oslo Universitetssykehus, Radiumhospitalet, Oslo

Sykehuset Østfold (Kalnes/Sarpsborg), Sarpsborg

Universitetssjukehuset i Stavanger, Stavanger

University Hospital of North Norway, Pulmonology Department, Tromsø

Cancer Clinic at St. Olavs Hospital, Trondheim

Gävle Sjukhus, Gävle

Sahlgrenska Sjukehuset, Gothenburg

Skånes universitetssjukhus, Lund

Universitetssjukehuset i Ôrebro, Örebro

Karolinska University Hospital, Stockholm

Norrlands Universitetssjukehus, Umeå

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

Oslo University Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

collaborator

Sorlandet Hospital HF

OTHER_GOV

lead

Norwegian University of Science and Technology

OTHER

NCT02041845 - Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter